Close X
Get more out of
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.

Click here if you're interested
Helping you make better health choices

What Doctors Don't Tell You

In shops now or delivered to your home from only £3.50 an issue!

July 2020 (Vol. 5 Issue 5)


About the author: 

Arava image

The days of Arava (leflunomide) may be numbered

The days of Arava (leflunomide) may be numbered. The drug, which treats rheumatoid arthritis, has been linked to 12 deaths in the USA alone.

The Food and Drug Administration, the US drug regulator, has received 130 reports of severe liver toxicity from people taking the drug since it was licensed for use in 1998. Of these, 56 were treated in hospital, and 12 died. Two of those who died were in their 20s.

Similar reactions have been reported in Europe, and the European Agency for the Evaluation of Medicinal Products issued an urgent warning last year to patients and doctors about the drug's toxicity.

Public Citizen, a consumer watchdog group, has petitioned the FDA to remove the drug from the marketplace. In a comparison between leflunomide and methotrexate, another antiarthritic drug, leflunomide was linked to six times more cases of fatal liver toxicity and 13 times more reports of hypertension than methotrexate, even though five times more prescriptions had been written for methotrexate.

The drug was also linked to 12 cases of Stevens-Johnson syndrome, a serious systemic skin condition, an adverse reaction not seen with methotrexate.

The drug stays in the body for a long time so that, even if a patient stops taking it, the adverse reactions may continue for months afterwards.

Side-effects include diarrhoea, nausea, vomiting and anorexia, headache, dizziness, hair loss, eczema, dry skin, jaundice, anxiety, ruptured tendons and anaemia.

The link with possibly fatal liver toxicity was suspected at the time of licensing, but it has taken a citizen's group action to force the regulator's hand. 'No more patients should be subjected to these risks,' says Dr Sidney Wolfe of Public Citizen.

Let's hope that the regulators on both sides of the Atlantic agree - and quickly.

Osteomyelitis image


Why did the anorak-wearer cross the road? image

Why did the anorak-wearer cross the road?

You may also be interested in...

Support WDDTY

Help support us to hold the drugs companies, governments and the medical establishment accountable for what they do.


Latest Tweet


Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions..

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

© 2010 - 2020 WDDTY Publishing Ltd.
All Rights Reserved